Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design
Authors
Keywords
Heart failure, Diabetes, SGLT2 inhibitor, Mechanistic trial, Cardiac MRI, Cardiopulmonary exercise testing
Journal
Cardiovascular Diabetology
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-15
DOI
10.1186/s12933-016-0419-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection FractionCLINICAL PERSPECTIVE
- (2016) Søren L. Kristensen et al. Circulation-Heart Failure
- Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial
- (2016) David Fitchett et al. EUROPEAN HEART JOURNAL
- Management of Noncardiac Comorbidities in Chronic Heart Failure
- (2015) Vun Heng Chong et al. Cardiovascular Therapeutics
- Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes: Table 1
- (2015) Colleen Majewski et al. DIABETES CARE
- Mean HbA1cand mortality in diabetic individuals with heart failure: a population cohort study
- (2015) Douglas H.J. Elder et al. EUROPEAN JOURNAL OF HEART FAILURE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin in the treatment of type 2 diabetes: evidence to date
- (2015) Jay Shubrook et al. Drug Design Development and Therapy
- The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
- (2014) David ZI Cherney et al. Cardiovascular Diabetology
- Physical Activity Measured With Implanted Devices Predicts Patient Outcome in Chronic Heart Failure
- (2014) Viviane M. Conraads et al. Circulation-Heart Failure
- Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension
- (2014) Ilkka Tikkanen et al. DIABETES CARE
- Blood pressure effects of sodium–glucose co-transport 2 (SGLT2) inhibitors
- (2014) Raymond V. Oliva et al. Journal of the American Society of Hypertension
- Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
- (2014) Michael Nauck Drug Design Development and Therapy
- Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology
- (2014) Sanjay Kalra Diabetes Therapy
- Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
- (2013) David Z.I. Cherney et al. CIRCULATION
- Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology
- (2013) Richard M Cubbon et al. Diabetes & Vascular Disease Research
- Association of sulphonylurea treatment with all-cause and cardiovascular mortality: A systematic review and meta-analysis of observational studies
- (2013) Thomas Forst et al. Diabetes & Vascular Disease Research
- Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin
- (2013) Sunder Mudaliar et al. Diabetes Technology & Therapeutics
- High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease
- (2013) Sushma Rekhraj et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- The effect of metformin on insulin resistance and exercise parameters in patients with heart failure
- (2012) Aaron K.F. Wong et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
- (2012) Jan Bolinder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-term treatment with empagliflozin, a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats
- (2011) L. Thomas et al. DIABETES OBESITY & METABOLISM
- Left Ventricular Remodeling in Heart Failure
- (2011) Marvin A. Konstam et al. JACC-Cardiovascular Imaging
- Effect of Metformin on Mortality in Patients With Heart Failure and Type 2 Diabetes Mellitus
- (2010) Josie M.M. Evans et al. AMERICAN JOURNAL OF CARDIOLOGY
- Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study
- (2010) C. Andersson et al. DIABETOLOGIA
- Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction
- (2010) Daniel G. Kramer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Heart Disease and Stroke Statistics—2010 Update
- (2009) et al. CIRCULATION
- Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure
- (2009) Christopher M. O’Connor et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
- (2008) S. Han et al. DIABETES
- Diabetes, left ventricular systolic dysfunction, and chronic heart failure
- (2008) Michael R. MacDonald et al. EUROPEAN HEART JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started